Browse Related Topics For:

Generic Drugs

497
Pharmaceutical Industry
303
Patents
286
Pharmaceutical Patents
284
Prescription Drugs
239
Patent Infringement
227
FDA
221
ANDA
209
Patent Litigation
170
Hatch-Waxman
83
SCOTUS
80
FTC
66
Reverse Payment Settlement Agreements
63
Biosimilars
61
FTC v Actavis
61
Pay-For-Delay
57
Actavis Inc.
52
Preemption
46
Antitrust Litigation
46
Teva Pharmaceuticals
43
Patent-in-Suit
43
Popular
42
Mylan Pharmaceuticals
41
Manufacturers
34
BPCIA
33
Appeals
31
Labeling
30
FDCA
29
Apotex
29
Healthcare
28
FDA Approval
28
Sandoz
27
Failure To Warn
26
Medical Devices
24
AstraZeneca
24
Inter Partes Review (IPR) Proceeding
23
Drug Pricing
22
Amgen
22
Biologics
22
DOJ
22
Sherman Act
22
Watson Pharmaceuticals
21
Merck
21
Prior Art
20
Anti-Competitive
20
Class Action
20
Novartis
19
Antitrust Violations
19
Medicare
19
Patent Trial and Appeal Board
19
Warning Labels
18
Affordable Care Act
18
Biotechnology
18
Commercial Marketing
18
Design Defects
18
Medicaid
18
Settlement
17
Intellectual Property Protection
17
Obviousness
17
Patent Applications
17
Preliminary Injunctions
17
Product Hopping
17
Sandoz v Amgen
16
Bayer
16
Eli Lilly
16
Infringement
16
Mutual Pharmaceuticals v Bartlett
16
Orange Book
16
PLIVA v Mensing
16
USPTO
15
Antitrust Provisions
15
EU
15
Patent Dance
15
Patent Invalidity
15
Pharmacies
15
Summary Judgment
14
Corporate Counsel
14
Declaratory Judgments
14
Hospira
14
Innovator Liability
14
Personal Jurisdiction
13
HHS
13
Safe Harbors
12
America Invents Act
12
Cephalon
12
Life Sciences
12
Notice Requirements
12
OIG
12
Rule-of-Reason Analysis
11
CA Supreme Court
11
China
11
Jurisdiction
11
Product Exclusivity
10
CMS
10
GlaxoSmithKline
10
On-Sale Bar
10
Pfizer
10
Warner Chilcott
9
Dismissals
9
Endo Pharmaceuticals
9
False Claims Act (FCA)
9
Health Care Providers
9
Hedge Funds
9
Hospitals
9
Otsuka Pharmaceutical
9
Price-Fixing
9
Reverse Payments
9
Trademarks
8
Allergan Inc
8
Attorney Generals
8
Competition
8
Enforcement Actions
8
Gilead Sciences
8
Monopolization
8
Proposed Legislation
8
Wyeth
7
Federal Budget
7
Motion to Dismiss
7
Nexium
7
No-AG Agreement
7
Noninfringement
7
Orphan Drugs
7
Product Defects
7
Product Labels
7
RanBaxy
7
REMS
7
Roxane Laboratories
7
Suppliers
7
Takeda Pharmaceuticals
6
AbbVie
6
Abuse of Process
6
Anti-Kickback Statute
6
Antitrust Investigations
6
Canada
6
Civil Monetary Penalty
6
Claim Construction
6
Congressional Investigations & Hearings
6
Draft Guidance
6
Exclusivity
6
Exports
6
Government Investigations
6
Intellectual Property Litigation
6
Janssen Pharmaceuticals
6
Jazz Pharmaceuticals
6
Medicare Part B
6
Mensing
6
Misrepresentation
6
New Legislation
6
Par Pharmaceutical
6
Post-Grant Review
6
Proposed Regulation
6
Putative Class Actions
6
Rebates
6
Settlement Agreements
5
aBLA
5
Biologics Price Competition and Innovation Act of 2009
5
Brand
5
Cartels
5
Causation
5
Cipro
5
Class Certification
5
Comment Period
5
Compliance
5
Drug Safety
5
European Commission
5
Induced Infringement
5
Innovation
5
Legislative Agendas
5
Martin Shkreli
5
Medicare Part D
5
Off-Label Promotion
5
Patent-Eligible Subject Matter
5
Pleading Standards
5
Professional Conferences
5
Reversal
5
SEC
5
Standing
5
Trump Administration
5
UK
4
Abbott Laboratories
4
Amarin
4
Anticompetitive Agreements
4
Antitrust Division
4
Australia
4
Boehringer
4
Cancer
4
Cartwright Act
4
Citizen Petitions
4
Classen Immunotherapies
4
DaimlerAG
4
Disgorgement
4
Doctrine of Equivalents
4
Duty to Deal
4
Federal Rule 12(b)(6)
4
First Amendment
4
Forest Laboratories
4
Forum Shopping
4
Genentech
4
Health Insurance
4
Johnson & Johnson
4
Kickbacks
4
Marketing
4
Medicare Modernization Act
4
Mental Health
4
OPPS
4
Pending Legislation
4
Permanent Injunctions
4
Real Party in Interest
4
Research and Development
4
Section 340B
4
Spectrum
4
Subpoenas
4
Third-Party Relationships
4
Trans-Pacific Partnership
4
Unfair Competition
3
21st Century Cures Initiative
3
Acquisitions
3
Allergan v Sandoz
3
Antitrust Conspiracies
3
Arbitration
3
Burden of Proof
3
Clinical Trials
3
Competition Authorities
3
Congressional Committees
3
Cost-Sharing
3
Criminal Antitrust Litigation
3
DaimlerChrysler v Bauman
3
Data Protection
3
De Novo Standard of Review
3
Debt Ceiling
3
Direct Purchasers
3
Elan Pharmaceuticals
3
Estoppel
3
False Advertising
3
FCPA
3
First Sale Doctrine
3
France
3
French Competition Authority
3
Fresenius
3
GDUFA
3
General Jurisdiction
3
Generic
3
Google
3
Healthcare Reform
3
Hoffman LaRoche
3
Imports
3
Injunctions
3
Injunctive Relief
3
Innovation Act
3
Joinder
3
Laches
3
Learned Intermediary
3
Licensing Rules
3
Manufacturing Defects
3
Medical Research
3
Mergers
3
Minimum Contacts
3
Motion for Sanctions
3
Multidistrict Litigation
3
Obama Administration
3
Off-Label Use
3
Opioid
3
Patent Term Adjustment
3
Physician Fee Schedule
3
Physicians
3
Public Health Service Act
3
Qui Tam
3
Retailers
3
RICO
3
Rule 23
3
Rulemaking Process
3
Rural Areas
3
Sequestration
3
SmithKline Beecham
3
Specific Jurisdiction
3
Telehealth
3
TFEU
3
Twombly/Iqbal Pleading Standard
3
Unjust Enrichment
3
Vacated
3
Whistleblowers
3
Wholesale
2
Abuse of Dominance
2
Actos
2
Ambulatory Surgery Centers
2
Anticompetitive Behavior
2
Antitrust Injuries
2
Automatic Enrollment
2
Barack Obama
2
Biopharmaceutical
2
Breach of Warranty
2
Bribery
2
Burden-Shifting
2
Cadillac Tax
2
CAFC
2
Calculation of Damages
2
CDC
2
Chevron Deference
2
Co-Op
2
Consent Order
2
Contraceptive Coverage Mandate
2
Copyright
2
Copyright Infringement
2
Corruption
2
Covered Business Method Patents
2
Dairy Farmers
2
Damages
2
Declaratory Relief
2
Direct Infringement
2
Disclosure
2
Discovery
2
Divestiture
2
Drug Approvals
2
Drug Compounding
2
Durable Medical Equipment
2
Duty to Warn
2
E-Cigarettes
2
En Banc Review
2
Expert Testimony
2
Failure To State A Claim
2
Federal Aviation Administration (FAA)
2
Federal Question Jurisdiction
2
Final Rules
2
Financial Sector
2
Food and Drug Administration Amendments Act (FDAAA)
2
Food Safety
2
Foreign Manufacturers
2
FQHC
2
Fraud
2
Free Speech
2
FTC Act
2
Health Canada
2
Health Information Technologies
2
Healthcare Costs
2
India
2
Interlocutory Injunctions
2
International Arbitration
2
International Harmonization
2
INTERPOL
2
Inventions
2
Inventors
2
IP License
2
Italy
2
Japan
2
John Boehner
2
Joint Venture
2
Jury Verdicts
2
Kmart
2
Lanham Act
2
License Agreements
2
Licenses
2
Medicare Prescription Drug Improvement and Modernization Act (MMA)
2
MedPAC
2
Medtronic
2
Method Claims
2
Motion for Reconsideration
2
Motion To Stay
2
Multinationals
2
Native American Issues
2
Negligence
2
New Guidance
2
NIH
2
Non-Compete Agreements
2
Numerosity
2
Nursing Homes
2
Octane Fitness v. ICON
2
Offsets
2
Out-of-State Companies
2
OxyContin
2
PATENT Act
2
Patent Owner Preliminary Response
2
Patent Reform
2
Patent Term Extensions
2
Patients
2
Petition for Writ of Certiorari
2
Pharmacist
2
PHRMA
2
Physician Medicare Reimbursements
2
PMNOC Regulations
2
Predominance Requirement
2
Prescription Drug Coverage
2
Presidential Elections
2
Presumption of Validity
2
Prilosec
2
Private Right of Action
2
Profits
2
Proposed Amendments
2
Public Disclosure
2
Public Health
2
Recordkeeping Requirements
2
Remuneration
2
Risk Mitigation
2
Sanofi
2
Sanofi-Aventis
2
Schering-Plough
2
Shire Development v Watson
2
SNDAs
2
Software
2
Standard of Review
2
State Law Tort Claims
2
Stocks
2
Strategic Enforcement Plan
2
STRONG Patents Act
2
Subject Matter Jurisdiction
2
Substance Abuse
2
Supplementary Protection Certificate
2
Tariffs
2
Telemedicine
2
Teva v Sandoz
2
Textiles
2
The Clayton Act
2
Trade Relations
2
Trademark Registration
2
Transfer of Venue
2
TRIPS Agreement
2
TRO
2
UK Competition and Markets Authority (CMA)
2
Uniform Commercial Code (UCC)
2
User Fees
2
Webinars
2
Websites
2
White Collar Crimes
2
WTO
2
Young Lawyers
1
35 U.S.C. § 271(e)(1)
1
3D Printing
1
510(k) RTA
1
Acceleration
1
ACOs
1
Administrative Proceedings
1
Advance Notice
1
Advertising
1
Affirmative Defenses
1
Aircraft
1
AL Supreme Court
1
Alien Tort Statute
1
Alternative Payment Models (APM)
1
Ambiguous
1
Ambulance Providers
1
Amended Complaints
1
Amended Regulation
1
Amgen v Apotex
1
Amgen v Sandoz
1
Amnesty
1
AMP v Myriad
1
Anti-Bribery
1
Anti-Corruption
1
Anti-Monopoly
1
Antibiotics
1
App Developers
1
Apple
1
Apportionment
1
Asia Pacific
1
Assignments
1
Aurobindo Pharmaceuticals
1
Australian Competition and Consumer Commission
1
Auto Manufacturers
1
Auto Parts
1
Automatic Stay
1
Automotive Industry
1
Aviation Industry
1
Bad Debt
1
Banking Sector
1
Banks
1
Barclays
1
Bausch & Lomb
1
Best Practices
1
Bid Rigging
1
Bifurcation
1
Biogen Idec
1
Bipartisan Budget
1
Bipolar Disorder
1
Birth Defects
1
Boeing
1
Books
1
Bowman v Monsanto
1
Boycotts
1
BPCI
1
Brand Name Prescription Drugs
1
Brazil
1
Breach of Contract
1
Bristol-Myers Squibb
1
Brokers
1
BSA/AML
1
Bundled Payments
1
Cadence Pharmaceuticals Inc.
1
CADTH
1
CAFA
1
Carve Out Provisions
1
Cease and Desist Orders
1
Celltrion
1
Center for Drug Evaluation and Research (CDER)
1
CEOs
1
CETA
1
CFDA
1
Charitable Organizations
1
Charitable PAPs
1
Cisco v CommilUSA
1
Citron Pharmaceuticals
1
CJEU
1
Class Members
1
Classification
1
Clear and Convincing Evidence
1
Clearance
1
CLIA
1
Co-payments
1
Collateral Estoppel
1
Color Marks
1
Comcast v. Behrend
1
Community Trademark
1
Compensation
1
Competition Act
1
Complex Litigation
1
Confidential Information
1
Confidentiality Agreements
1
Conflicting Proposals
1
Constitutional Challenges
1
Consumer Fraud
1
Consumer Product Safety Commission (CPSC)
1
Contingency Fees
1
Continuing Legal Education
1
Contraceptives
1
Copyright Litigation
1
Corporate Executives
1
Corrective Actions
1
Counterclaims
1
Counterfeit Drugs
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Proceedings
1
Credit Suisse
1
Criminal Prosecution
1
Customer-Loyalty Programs
1
CVS
1
Cybersecurity
1
Daiichi Sankyo
1
Data Breach
1
Data Collection
1
DE Supreme Court
1
Decriminalization of Marijuana
1
Defect
1
Deferred Prosecution Agreements
1
Deficit Reduction
1
Delaware General Corporation Law
1
Delay Claims
1
Denial of Certiorari
1
Department of Veterans Affairs
1
Design Patent
1
Designer Professionals' Liability
1
Device Classification
1
DHS
1
Diagnostic Tests
1
Dietary Supplements
1
Directed Verdicts
1
Disclosure Requirements
1
Discovery Disputes
1
Discovery Rule
1
Dismissal With Prejudice
1
Disparagement
1
Dispute Resolution
1
Distributors
1
Diversity Jurisdiction
1
Divided Infringement
1
Divisional Applications
1
DMCA
1
DOHA
1
DOL
1
Double Patent
1
DQSA
1
Drug Distribution
1
Drug Wholesaling
1
Duty of Care
1
Duty to Update
1
EAR
1
Edith Ramirez
1
EHR
1
Elder Issues
1
Email
1
Emerging Markets
1
Employer Mandates
1
Energy Sector
1
Enforcement
1
Entertainment Industry
1
EPA
1
European Patent Office
1
Evidence
1
Evidence Suppression
1
Exceptional Case
1
Exceptions
1
Excessive Pricing
1
Exclusive Licenses
1
Exclusive Remedy
1
Export Controls
1
Extraterritoriality Rules
1
Facebook
1
Fair Use
1
False Evidence
1
False Statements
1
FBI
1
FD&C Act
1
FDA Reauthorization Act
1
FDASIA
1
Federal Jurisdiction
1
Federal Register
1
Federal Rule 12(b)(1)
1
Federal Rules of Civil Procedure
1
Federal Trade Commission Act
1
Fee-for-Service
1
FERA
1
Filing Fees
1
Financial Crisis
1
Financial Instruments
1
Financial Markets
1
Fines
1
Food Contamination
1
Food Labeling
1
Food Recalls
1
Foreign Corporations
1
Foreign Exchanges
1
Foreign Investment
1
Foreign Trade Regulations
1
Foreseeability
1
Form 8-K
1
Forum
1
Forum Non Conveniens
1
Forum Selection
1
FRAND
1
Fraud and Abuse
1
Fraudulent Concealment
1
Fraudulent Inducement
1
Fraudulent Procurement
1
FRCP 23(b)(3)
1
FTEs
1
General Court of the European Union (GCEU)
1
Genetically Engineered Seed
1
Genzyme
1
Germany
1
Good Clinical Practices
1
Goodyear
1
Governor Brown
1
Governor Cuomo
1
Grable Factors
1
Grand Juries
1
Grocery Stores
1
Guilty Pleas
1
Gun-Jumping
1
Hart-Scott-Rodino Act
1
Hazardous Waste
1
Health Safety
1
Healthcare Facilities
1
Healthcare Fraud
1
HEAT
1
HELP
1
Hepatitis C
1
Highmark
1
Highmark v. Allcare
1
Hillary Clinton
1
HIPAA
1
Home Health Care
1
Honeywell International
1
Hospital Mergers
1
Hotels
1
HRSA
1
Human Genes
1
ICD-10
1
ICSID
1
Imminent Harm
1
Implied Preemption
1
Income Taxes
1
Indirect Purchasers
1
Inducements
1
Inflation Adjustments
1
Information Disclosure Statement
1
Information Reports
1
Information Sharing
1
Informed Consent
1
Inspections
1
Inspector General
1
Insurance Industry
1
Intent-to-Use
1
Interest Rates
1
Interlocutory Appeals
1
International Treaties
1
Investigational New Drug Application (IND)
1
Investment
1
Investment Management
1
Investors
1
IRF Claim Processing
1
Irreparable Harm
1
IRS
1
Issue Preclusion
1
ITC
1
Judges
1
Judgment on the Pleadings
1
Jury Awards
1
Justiciable Controversy
1
King v Burwell
1
Kirtsaeng v. John Wiley & Sons
1
Leave to Amend
1
Leave to Appeal
1
Lenz v Universal Music Corp.
1
LG Electronics
1
Libor
1
Likelihood of Success
1
Limelight v Akamai
1
Lipitor
1
Long Term Care Facilities
1
Loss Causation
1
Low-Income Issues
1
MACs
1
Market Manipulation
1
Marketing Authorization Application
1
Material Defects
1
Material Misrepresentation
1
Materiality
1
Mayne Pharmaceuticals
1
Media
1
Medical Foods
1
Medical Marijuana
1
Medicare Advantage
1
Medicare Advantage Organizations (MAOs)
1
Member State
1
Merger Controls
1
Mexico
1
Microsoft
1
Ministry of Health
1
Mistrial
1
Monsanto
1
Mootness
1
Motion for Summary Judgment
1
Motion To Centralize
1
Motion to Compel
1
Motorola
1
Mylan Pharmaceuticals Inc v Acorda Theraputics Inc
1
Myriad
1
NAFTA
1
National Security
1
Negligent Design
1
Negotiations
1
New Regulations
1
New Trial
1
Nexus
1
Nike
1
NJ Supreme Court
1
Nominations
1
Non-Grandfathered Health Plans
1
Non-Prosecution Agreements
1
Notice of Intent
1
Notifications
1
Nutritional Supplements
1
OCR
1
OFAC
1
Office Depot
1
Omissions
1
Omnicare
1
Online Drug Sales
1
Open Enrollment
1
OTDP
1
Out-of-State Judgments
1
PACE
1
Pain Management Clinics
1
Panasonic
1
Parallel Claims
1
Patent Assertion Entities
1
Patent Exhaustion
1
Patent Filings
1
Patent Prosecution
1
Patent Terms
1
Patent Trolls
1
Patent Validity
1
Patent-Misuse
1
Patentability Search
1
Patented Medicine Prices Review Board (PMPRB)
1
Patient Assistance Programs
1
Patient Self-Referral
1
Pay-to-Delay System
1
Pharmaceutical Benefits Scheme
1
Pharmaceutical Distribution
1
Pharmaceutical Reverse Distributors
1
PHSA
1
Physician Payments
1
Political Campaigns
1
Political Candidates
1
Post-Market Approval
1
Pretext
1
Price Manipulation
1
Price Transparency
1
Prince
1
Proctor & Gamble
1
Prometheus
1
Promotional Items
1
Proposed Rules
1
Public Hearing
1
Public Meetings
1
Public Performance Rights
1
Public Procurement Policies
1
Public Transportation
1
Public Use
1
Purchase Agreement
1
Rare Earth Metals
1
Reauthorization
1
Registration
1
Registration Requirement
1
Regulatory Agenda
1
Regulatory Oversight
1
Regulatory Standards
1
Reimbursements
1
Reissue Patents
1
Relators
1
Remedies
1
Renewal Fees
1
Reporting Requirements
1
Res Ipsa Loquitur
1
Restraining Orders
1
Restraint of Trade
1
Risk Assessment
1
Risk Management
1
RMBS
1
ROI
1
Rule 11
1
Rules of Civil Procedure
1
Rupert Murdoch
1
Rural Health Care Program
1
Safety Precautions
1
Sales Contracts
1
SAMHSA
1
Samsung
1
SCA Hygiene Products Aktiebolag v First Quality Baby Products
1
Section 2
1
Section 8
1
Securities
1
Securities Fraud
1
Senate Judiciary Committee
1
SFDA
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Shell Oil
1
Skilled Nursing Facility
1
Social Security
1
Solar Energy
1
Solar Panels
1
Solicitor General
1
Spoliation
1
Sponsors
1
Sports
1
Standard Essential Patents
1
Standard of Proof
1
Standing Objections
1
Staples
1
State Health Insurance Exchanges
1
Stem cells
1
Stock Drop Litigation
1
Structured Financial Products
1
Subsidies
1
Supply Chain
1
Supreme Court of Canada
1
Surveillance
1
Surveys
1
Takedown Notices
1
Tax Credits
1
Teamsters
1
Technology Transfer Agreements
1
Television Service Providers
1
Textbooks
1
The Patent Act
1
Tobacco Regulations
1
Tolling
1
Tortious Interference
1
Toshiba
1
Trade Agreements
1
Trade Promotion Authority
1
Trade Secrets
1
Trademark Application
1
Trademark Searches
1
Transfer of Title
1
Transparency
1
Transvaginal Mesh
1
TRICARE
1
Twentieth Century Fox
1
Two-Midnight Rule
1
Tyco
1
U.S. Treasury
1
Unfair Pricing
1
Unitary Patent
1
Universal Health Services Inc v United States ex rel Escobar
1
Utility Patents
1
Vaccinations
1
Valeant
1
Veterans
1
Veterans Administration
1
Veterinary Products
1
Viagra
1
Walker Process Claims
1
Warranties
1
Wells Fargo
1
Willful Infringement
1
WIPO
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
Work Plans
1
World Intellectual Property Organisation
1
Written Notice
1
Wrongful Death
1
Yahoo!
1
YouTube
Feedback? Tell us what you think of the new jdsupra.com!